| (210) | Number of the EPO application | 19765421 |
| (220) | Filing date of the EPO application | 2019.08.28 |
| (80) | EPO patent specification publication (B) | EPB nr. 37/2023, 2023.09.13 |
| (110) | EPO patent number | 3843715 |
| (11) | Number of the document | MD 3843715 T2 |
| (21) | Number of the application | e 2021 0608 |
| (71) | Name(s) of applicant(s), code of the country | Selo Medical GmbH, AT; |
| (72) | Name(s) of inventor(s), code of the country | FUCHS Norbert, AT; |
| (73) | Name(s) of owner(s), code of the country | SELO MEDICAL GMBH, AT; |
| (54) | Title of the invention | Therapy of high-risk human papillomavirus infections |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | A61K 31/185 (2006.01.01); A61K 31/19 (2006.01.01); A61K 31/191 (2006.01.01); A61K 9/00 (2006.01.01); A61K 9/06 (2006.01.01); A61K 47/38 (2006.01.01); A61K 33/04 (2006.01.01); A61P 31/12 (2006.01.01) |
| (19) | Country | AT |
| (41) | Date of publication of the application | 2021.08.31 |
| (49) | Date of publication of the translation of the validated European patent specification | 2023.12.31 |
| (30) | Priority | 18191289, 2018.08.28, EP |
| (74) | Patent attorney | (Procedură) SOCOLOVA Sofia, Str. Drumul Viilor nr. 42, bloc 3, ap. 60, MD-2021, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2019/072926, 2019.08.28 |
| (87) | International publication | WO 2020/043762, 2020.03.05 |